Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 1998, p. 2784-2785, Vol. 36, No. 9
Department of Pathology, Universidad Peruana
Cayetano Heredia, Lima, Peru,1 and the
Department of International Health, Johns Hopkins
University, Baltimore, Maryland2
Received 9 December 1997/Returned for modification 26 March
1998/Accepted 22 May 1998
Metronidazole and tetracycline E tests were compared to an agar
dilution method for the antimicrobial susceptibility testing of
Helicobacter pylori. Sixteen strains were tested by using
tetrazolium egg yolk (TEY) agar. The characteristic E test inhibition
ellipse was clearer on TEY agar than on standard blood agar and gave
results comparable to those of the agar dilution test. The use of TEY medium is preferable to that of blood agar medium in E test MIC determinations for H. pylori.
The gastric pathogen
Helicobacter pylori is the major etiological agent of
chronic gastritis and peptic ulcers and a major risk factor for gastric
cancer (2, 7). Eradication of H. pylori
prevents peptic ulcer recurrence and may also decrease the
prevalence of gastric cancer in high-risk populations
(2-4). Though metronidazole is often used to
treat H. pylori in the United States, resistance to
metronidazole is common in developing countries (8), leading to very frequent failure of
metronidazole-based anti-H. pylori therapy (6).
Increasing resistance to several other antimicrobial agents, including
clarithromycin, has focused new attention on the need for reliable
methods for determining drug susceptibility (1, 9). The
current standard method uses agar dilution to determine the MIC of an
antimicrobial agent. However, this technique is time consuming and
tedious.
The Epsilometer test (E test; AB Biodisk, Solna, Sweden) is simple to
use and yields MICs that agree well with those obtained by the
"gold standard" agar dilution methods and that are relatively unaffected by variations in inoculum size. The E test is becoming increasingly popular for the determination of MICs for H. pylori, usually by using one of the many blood agar-based
media, although the medium, inoculum size, and growth conditions have
not been standardized. Our previous results showed that tetrazolium egg yolk (TEY) agar is extremely convenient for determining the MICs of
metronidazole and other antimicrobial agents by standard agar dilution
methods (9). Egg yolk emulsion, which forms the base of egg
yolk agar, is available commercially in the United States (Oxoid USA
Inc., Columbia, Md.). TEY agar contains an oxidation-reduction indicator (tetrazolium red) which changes from yellow to red when bacterial growth occurs: even the very small red H. pylori
colonies are easily visible, and confluent growth is very obvious
against the yellow background of the agar (9). In contrast,
on blood agar, the growth or elliptical zone of H. pylori is
hard to see, making the endpoint or elliptical zone difficult to
establish with certainty.
The purpose of this study is to test the validity of using TEY agar for
E testing. We have compared E test MIC determinations with those
obtained in parallel using our miniwell MIC technique. The E test
strips for metronidazole and tetracycline were used as recommended by
the manufacturer. MICs were determined in the miniplate format in TEY
agar as described previously (9).
Sixteen different H. pylori isolates were revived from
cryoconserved strains that were grown on blood agar (brucella agar with
5% sheep blood, amphotericin [6 µg/ml], and Skirrow's antibiotics [10 µg of vancomycin, 5 µg of trimethoprim, 2.5 IU of polymyxin B
per ml]). Colonies were then picked and grown on a standard blood agar
plate without antimicrobial agents. The strains were adjusted to a
density of 0.5 to 1 McFarland standard (1.5 × 108 to
3 × 108 CFU), 100 µl was spread on 90-mm-diameter
TEY agar petri plates, and 7 µl was inoculated into the
antibiotic-containing TEY agar in each well of standard 24-well tissue
culture plates (9). E test strips were placed on the plates
as soon as the inoculum was absorbed into the agar. The plates were
incubated at 37°C under microaerophilic conditions (5%
O2, 10% CO2, and 85% N) (9). Three
days later the MIC was read in both the E strip and the miniwell
plates. The MIC was defined as the lowest concentration of each
antibiotic resulting in complete inhibition, i.e., no colonies
(5). The two tests were considered to be in agreement when
their MICs were within 2 dilutions of each other and remained within
the same category of resistant or susceptible (10).
The E test was also quite reproducible. The coefficient of agreement
when the test was done in duplicate was 86% for metronidazole (n = 15 strains) and 93% for tetracycline
(n = 14 strains).
The E test was also extremely easy to read, since there was a clearly
defined elliptical inhibitory zone against the yellow background. There
was 100% agreement between the E test and the miniwell format for the
MICs of both metronidazole and tetracycline by the 2-dilution
definition. In 8 of 16 and 13 of 16 strains tested for metronidazole
and tetracycline susceptibility, respectively, there was a difference
of 1 dilution between MICs determined by the two methods. Occasionally
a H. pylori strain that was resistant to metronidazole
produced an unclear zone in the E test due to the presence of very
small colonies in the inhibitory zone. The correlation between the
results of the two methods assessed for metronidazole and tetracycline
is shown in the Table 1.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Antimicrobial Susceptibility of Helicobacter
pylori Determined by the E Test Using Tetrazolium Egg Yolk
Agar
,*
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Comparison of MICs for H. pylori isolates
obtained by agar dilution in miniwell format and by E test in
petri dishes
In general, MIC results in the miniwell format were slightly higher than those obtained with the E test for the two drugs. Our results validate the use of the E test on TEY agar to determine the MIC of metronidazole or tetracycline appropriate for testing strains of H. pylori. The test was reproducible and accurate. The TEY agar produced a clear and easily readable inhibitory zone, and there was good agreement with the MICs given by the agar dilution technique. E test zones were generally clear, and MIC endpoints were easily read. Some resistant strains tested against metronidazole had an elliptical zone of inhibition that was not smooth at the E strip intersection. The highest drug concentration recorded on the E strip for metronidazole was 32 µg/ml, but in Peru we have found H. pylori strains that are resistant to up to 128 µg of metronidazole/ml. It is doubtful that this difference is of clinical significance. A Belgian study (1) also compared the E test and the agar dilution technique for 12 different antibiotics, including metronidazole and tetracycline. Results rarely differed by more than 2 dilution steps, and 44% of their strains were resistant to metronidazole, thus confirming the report of 50% in our previous study (9).
In this study we found three H. pylori strains for which the tetracycline MIC was 1 µg/ml in the miniwell determination. Borderline tetracycline-resistant strains such as these will bear watching to determine if tetracycline-resistant strains develop in the future. In many midlevel developing countries like Peru, where cost and simplicity are important and where metronidazole and perhaps clarithromycin resistance are common, the E test performed on TEY agar provides a cheap and simple method for the determination of antimicrobial resistance in H. pylori strains.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Dept. of International Health, Room 5521, Hopkins School of Hygiene, 615 N. Wolfe St., Baltimore, MD 21205. Phone: (410) 955-6964. Fax: (410) 550-6733. E-mail: Rgilman{at}jhsph.edu.
Member of the Gastrointestinal Physiology Working Group. The other
members are Robert Berendson, Raul Leon-Barua, Alberto Ramirez-Ramos,
and Sixto Recavarren-Arce, Department of Pathology, Universidad Peruana
Cayetano Heredia, Lima, Peru, and Jose Watanabe, Japanese Peruvian
Polyclinic, Lima, Peru.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Glupczynski, Y.,
M. Labbé,
W. Hansen,
F. Crokaert, and E. Yourassowsky.
1991.
Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.
J. Clin. Microbiol.
29:2072-2075 |
| 2. | Graham, D. Y. 1994. Determinants of antimicrobial effectiveness in Helicobacter pylori gastritis, p. 531-537. In R. H. Hunt, and G. N. J. Tytgat (ed.), Helicobacter pylori: basic research to clinical cure. Kluwer Academic Publishers, Boston, Mass. |
| 3. | Graham, D. Y., and M. F. Go. 1993. Helicobacter pylori: current status. Gastroenterology 105:279-282[Medline]. |
| 4. | Leon-Barua, R., S. Recavarren, R. Gilman, and R. Berendson. 1993. Can eradication of Helicobacter pylori prevent gastric cancer? Drugs 46:341-346[Medline]. |
| 5. | Megraud, F. 1994. Helicobacter pylori. Resistance to antibiotics, p. 570-583. In R. H. Hunt, and G. N. J. Tytgat (ed.), Helicobacter pylori: basic research to clinical cure. Kluwer Academic Publishers, Boston, Mass. |
| 6. | Ramirez-Ramos, A., R. Gilman, S. Recavarren, G. Salazar, and the Gastrointestinal Physiology Working Group. 1997. Rapid recurrence of Helicobacter pylori infection in Peruvian patients after eradication therapy. Clin. Infect. Dis. 25:1027-1031[Medline]. |
| 7. | Tytgat, G., L. Noach, and E. Rauws. 1993. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol. Clin. N. Am. 22:127-139[Medline]. |
| 8. | Tytgat, G., and L. Noach. 1994. Helicobacter pylori eradication, p. 550-569. In R. H. Hunt, and G. N. J. Tytgat (ed.), Helicobacter pylori: basic research to clinical cure. Kluwer Academic Publishers, Boston, Mass. |
| 9. | Vasquez, A., Y. Valdez, R. H. Gilman, J. J. McDonald, T. U. Westblom, D. Berg, H. Mayta, and V. Gutierrez. 1996. Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. J. Clin. Microbiol. 34:1232-1234[Abstract]. |
| 10. | Yao, J. D. C., M. Louie, L. Louie, J. Goodfellow, and A. E. Simor. 1995. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia. J. Clin. Microbiol. 33:1428-1430[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»